Showing results (2041-2050 of 2,348) with videos related to

Sort By:
Pageof 235
Addiction Biology|September 30, 2011
Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdalaMichal Bajo, Samuel G Madamba, Xiaoying Lu, et al.
Addiction Biology|September 30, 2011
The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addictionIgor Bazov, Olga Kononenko, Hiroyuki Watanabe, et al.
Addiction Biology|September 30, 2011
Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availabilityCleo L Crunelle, Elsmarieke van de Giessen, Sybille Schulz, et al.
Addiction Biology|October 15, 2011
Smaller right amygdala in Caucasian alcohol-dependent male patients with a history of intimate partner violence: a volumetric imaging studyLishu Zhang, Mike Kerich, Melanie L Schwandt, et al.
Addiction Biology|October 15, 2011
The effect of intravenous alcohol on the neural correlates of risky decision making in healthy social drinkersJodi M Gilman, Ashley R Smith, Vijay A Ramchandani, et al.
Addiction Biology|August 5, 2011
Chronic cocaine self-administration modulates ERK1/2 and CREB responses to dopamine receptor agonists in striatal slicesHanne M Hoffmann, Roser Nadal, Michel Vignes, et al.
Addiction Biology|August 5, 2011
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET studyClaire Leroy, Laurent Karila, Jean-Luc Martinot, et al.
Addiction Biology|October 19, 2011
Genome-wide significant association between alcohol dependence and a variant in the ADH gene clusterJosef Frank, Sven Cichon, Jens Treutlein, et al.
Addiction Biology|October 19, 2011
Genetic differences in the modulation of accumbal glutamate and γ-amino butyric acid levels after cocaine-induced reinstatementMiguel Miguéns, Fanny Botreau, Oscar Olías, et al.
Addiction Biology|January 21, 2012
Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersSharon L Walsh, Markus Heilig, Paul A Nuzzo, et al.
Pageof 235